SPONSOR

University of Texas Southwestern Medical Center

Total Trials

Recruiting

Phases

Phase 4, Phase 2, Phase 1, Phase 2, Phase 1, Phase 3, EARLY_Phase 1

Conditions studied: Sarcoidosis Vitamin D Insufficiency Heart Failure Inflammation Post Operative Pain Urolithiasis Ureter Calculi Stent Complication Psoriatic Arthritis (PsA)Transthyretin (TTR) Amyloid Cardiomyopathy

University of Texas Southwestern Medical Center is a clinical research sponsor with 26 registered studies on ClinicalTrials.gov, of which 26 are actively recruiting participants. Research covers conditions including Sarcoidosis, Vitamin D Insufficiency, Heart Failure, Inflammation.

The trial portfolio spans Phase 4, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Texas Southwestern Medical Center

How many clinical trials has University of Texas Southwestern Medical Center sponsored?

ClinicalMetric currently tracks 26 clinical trials sponsored by University of Texas Southwestern Medical Center, of which 26 are actively recruiting participants. These trials cover conditions including Sarcoidosis, Vitamin D Insufficiency, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Texas Southwestern Medical Center research focus on?

University of Texas Southwestern Medical Center clinical trials span Sarcoidosis, Vitamin D Insufficiency, Heart Failure, Inflammation, Post Operative Pain, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Texas Southwestern Medical Center clinical trial?

To participate in a University of Texas Southwestern Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Texas Southwestern Medical Center trials with current recruitment status updated daily.

University of Texas Southwestern Medical Center

Frequently Asked Questions — University of Texas Southwestern Medical Center

Clinical Trials by University of Texas Southwestern Medical Center

Vitamin D Homeostasis in Sarcoidosis

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

Nudging Parental Actions for Youth Suicide Prevention

Heat Waves and the Elderly - Cooling Modalities

Multicomponent Intervention Study- Blood Donors With High Cholesterol

A Polypill for Acute Coronary Syndrome

Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

HIV/HBV/HCV Triple Screening in Primary Care

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

UTSW NORC Pilot Spinal Cord Injury Dietary Program

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy

Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care

ET Stigma Response to Tremor Suppression

Laryngeal Cryotherapy for Refractory Neurogenic Cough

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma